Posts by John

Traws Pharma stock drops after the UK regulator delays a planned flu trial. Discover the impact of the MHRA's decision on the company's clinical pipeline.

Traws Pharma shares fall after UK regulators pause a planned flu drug trial. Get the latest details on the delay and what it means for the company's future.

Traws Pharma shares fall as UK regulators delay a key influenza drug trial. Learn about the impact of the MHRA's decision on the company's clinical pipeline.

China's NMPA has updated clinical trial guidelines to accelerate drug innovation, improve research efficiency, and align with global regulatory standards.

A breakthrough WA-developed stroke therapy is gaining global recognition. Learn how this innovation in neuroplasticity is improving recovery outcomes.

The EMA’s June 2026 board meeting focuses on critical medicine supplies, digital health integration, and streamlined regulatory pathways for new therapies.

Discover how AI and machine learning are revolutionizing clinical trial statistics, reducing development costs, and improving data accuracy in drug research.

Discover why healthcare AI devices are facing increased recalls. Learn about data drift, algorithm transparency, and FDA safety standards in our latest report.

Eli Lilly’s investment in Abridge highlights a critical, often ignored gap in clinical trial recruitment. Learn why the “handoff” is failing patients.

Researchers successfully delivered dopamine-producing gene therapy to the brain. Discover the clinical hurdles ahead for this Parkinson’s breakthrough.